Saira Ramasastry is Director at Mirum Pharmaceuticals, Inc. (MIRM). They have made 8 open-market trades across 4 companies since 2014, most recently 2026-06-01.
CIK 0001547959
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 8 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| MIRM | SELL · 10b5-1 | 2026-06-01 | 2026-06-02 | $100.00 | $398K | +7.5% | +35.8% | +5.9% |
| MIRM | SELL · 10b5-1 | 2026-05-15 | 2026-05-18 | $109.47 | $219K | +7.1% | +7.6% | +5.3% |
| MIRM | SELL · 10b5-1 | 2026-04-15 | 2026-04-16 | $96.90 | $194K | -2.4% | -0.8% | +25.7% |
| MIRM | SELL · 10b5-1 | 2026-03-16 | 2026-03-17 | $90.76 | $182K | -7.1% | +0.7% | +6.2% |
| MIRM | SELL · 10b5-1 | 2026-02-13 | 2026-02-17 | $102.09 | $204K | -11.4% | -12.9% | -8.3% |
| MIRM | SELL · 10b5-1 | 2026-01-15 | 2026-01-16 | $90.99 | $182K | +14.0% | +13.9% | +6.2% |
| MIRM | SELL · 10b5-1 | 2025-12-22 | 2025-12-23 | $80.00 | $400K | -4.5% | +20.0% | +11.7% |
| MIRM | SELL · 10b5-1 | 2025-12-18 | 2025-12-19 | $69.73 | $139K | +1.7% | +19.7% | +18.1% |
| MIRM | SELL | 2025-06-02 | 2025-06-04 | $46.12 | $641K | +14.0% | +14.1% | +68.1% |
| DAWN | SELL | 2024-06-21 | 2024-06-21 | $13.19 | $132K | -1.0% | +9.0% | +5.0% |
| VIR | SELL | 2024-06-11 | 2024-06-12 | $10.95 | $44K | -11.7% | -10.2% | -23.6% |
| MIRM | SELL · 10b5-1 | 2024-06-05 | 2024-06-07 | $25.68 | $128K | +26.7% | +46.2% | +69.5% |
| VIR | SELL · 10b5-1 | 2023-06-01 | 2023-06-02 | $25.67 | $90K | -3.7% | -8.9% | -53.1% |
| VIR | SELL | 2022-07-11 | 2022-07-13 | $30.00 | $150K | -2.1% | -4.7% | -31.7% |
| VIR | SELL · 10b5-1 | 2022-05-24 | 2022-05-25 | $23.82 | $40K | +13.1% | +6.0% | +6.7% |
| VIR | SELL | 2021-05-19 | 2021-05-20 | $43.73 | $875K | -3.2% | +6.9% | +0.7% |
| SGMO | SELL | 2020-12-17 | 2020-12-18 | $13.27 | $133K | +11.1% | +10.7% | -15.6% |
| SGMO | SELL | 2018-02-26 | 2018-02-27 | $24.88 | $235K | +12.1% | -19.1% | -34.3% |
| SGMO | SELL | 2017-11-17 | 2017-11-21 | $14.67 | $73K | +7.4% | +5.8% | +43.5% |
| SGMO | SELL · 10b5-1 | 2015-02-12 | 2015-02-13 | $15.00 | $150K | -31.7% | +0.3% | +0.3% |
| SGMO | SELL · 10b5-1 | 2014-08-08 | 2014-08-12 | $14.00 | $140K | -31.7% | +0.3% | +0.3% |
| SGMO | SELL · 10b5-1 | 2014-06-23 | 2014-06-25 | $15.53 | $86K | -31.7% | +0.3% | +0.3% |
| SGMO | SELL · 10b5-1 | 2014-03-17 | 2014-03-17 | $23.26 | $233K | -31.7% | +0.3% | +0.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.